DCM Shriram Q4 Revenue Jumps 11% on Chemical & Fenesta Growth

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
DCM Shriram Q4 Revenue Jumps 11% on Chemical & Fenesta Growth
Overview

DCM Shriram reported an 11% year-on-year rise in Q4 FY26 net revenues to Rs 3,193 crore. The company highlighted strong growth in its chemicals business and Fenesta Building Systems, while navigating price volatility in vinyl and cost pressures in sugar.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

DCM Shriram Reports Strong Revenue Growth in Q4 FY26

DCM Shriram's net revenues for the fourth quarter of FY26 increased by 11% year-on-year to INR 3,193 crore. For the full fiscal year FY26, net revenues climbed 12% to INR 13,538 crore.

Key Highlights

The company achieved significant revenue growth in its Chemicals business, up 32% in Q4, and Fenesta Building Systems, up 34% in Q4. Despite a 19% revenue increase in the Vinyl segment, it faced price volatility. The Sugar and Ethanol segment saw revenue decline by 3% due to rising sugarcane costs and inventory pressures.

Financial Performance

DCM Shriram Ltd. announced its Q4 FY26 earnings on May 15, 2026. Net revenues for the quarter reached INR 3,193 crore, an 11% increase from the previous year. Full-year net revenues for FY26 grew 12% to INR 13,538 crore, with Profit Before Depreciation, Interest, and Taxes (PBDIT) rising 15% to INR 1,694 crore.

Strategic Growth and Challenges

This revenue growth underscores the company's expansion in its chemicals and building systems divisions. The strong full-year PBDIT growth suggests improved profitability. However, challenges within the vinyl and sugar segments indicate potential margin pressures ahead.

Operational Updates and Investments

DCM Shriram commissioned its ECH plant in April 2026 and is proceeding with projects for aluminium chloride and calcium chloride at Bharuch. A 68 MW green power project in Kota is also underway. Approved capital expenditures include INR 217 crore for renewable power at Bharuch and INR 101 crore for epoxy-led formulated resins capacity expansion.

Future Outlook and Risks

The company expects its new ECH plant to reach 60-70% capacity utilization with healthy margins. The acquired epoxy business is projected to break even this year. Key risks to monitor include geopolitical uncertainties impacting energy and supply chains, price volatility in the vinyl segment, potential oversupply in the domestic hydrogen peroxide market, and rising sugarcane costs affecting sugar profitability. The impact of El Nino on agriculture and high cotton inventory are also noted concerns.

Key Financial Metrics

  • Q4 FY26 Net Revenues: INR 3,193 crore (up 11% YoY)
  • FY26 Net Revenues: INR 13,538 crore (up 12% YoY)
  • FY26 PBDIT: INR 1,694 crore (up 15% YoY)
  • Net Debt: INR 1,767 crore
  • Return on Capital Employed: 13%
  • Recommended Final Dividend: 200%
  • Fenesta Revenue Growth (Q4 FY26): 28% YoY
  • Chemicals Revenue Growth (Q4 FY26): 32% YoY
  • Vinyl Revenue Growth (Q4 FY26): 19% YoY
  • Sugar and Ethanol Revenue Decline (Q4 FY26): 3% YoY

What to Watch Next

Investors will be closely observing the ramp-up and margins of the ECH plant, potential government policy impacts on PVC pricing, the sugar segment's performance amid cost pressures, and Fenesta Building Systems' continued growth. The company's planned capital expenditure of INR 1,000-1,200 crore for FY27 will also be a significant focus.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.